Corpus Intelligence IC Memo — ENCOMPASS HEALTH LAKESHORE REHABILIT 2026-04-26 03:44 UTC
IC Memo — ENCOMPASS HEALTH LAKESHORE REHABILIT
Investment Committee Memorandum | AL | 100 beds | Grade C | EBITDA uplift $3.5M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH LAKESHORE REHABILIT

CCN 013025 | JEFFERSON, AL | 100 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH LAKESHORE REHABILIT is a 100-bed suburban community hospital in JEFFERSON, AL with $46.9M in net patient revenue and a -5.1% operating margin. The hospital serves a payer mix of 44.4% Medicare, 12.2% Medicaid, and 43.4% commercial.

Thesis: Turnaround. Our ML models identify $3.5M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.1% to 2.3% (+736bps).

Net Revenue HCRIS$46.9M
Current EBITDA COMPUTED$-2.4M
Operating Margin COMPUTED-5.1%
Occupancy HCRIS88.5%
Revenue / Bed COMPUTED$469K
Net-to-Gross HCRIS68.2%
Distress Probability ML47.3%

2. Market Context & Competitive Position

115
AL Hospitals
-8.5%
State Median Margin
29
Comparable Hospitals

AL has 115 Medicare-certified hospitals with a median operating margin of -8.5%. The target's margin of -5.1% places it above the state median. Among 29 size-comparable peers (50-200 beds), the median margin is -3.7%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (50-200), prioritizing same-state peers. 29 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH LAKESHORE REH (Target)AL100$46.9M-5.1%
CRESTWOOD MEDICAL CENTERAL164$258.9M14.6%
THOMAS HOSPITALAL164$244.7M6.2%
FLOWERS HOSPITALAL193$235.5M14.2%
SPRINGHILL MEMORIAL HOSPITALAL179$216.2M-3.8%
MARSHALL MEDICAL CENTERS SOUTHAL178$186.9M-6.3%
SOUTH BALDWIN REGIONAL MEDICALAL112$168.2M46.4%
CULLMAN REGIONALAL137$167.1M-4.9%
HELEN KELLER HOSPITALAL178$92.0M-28.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.5M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$985K+210bp18mo
Cost to Collect4.5%2.5%$939K+200bp12mo
Denial Rate Reduction12.0%6.5%$929K+198bp12mo
A/R Days Reduction5200.0%3800.0%$571K+122bp9mo
Clean Claim Rate88.0%96.0%$30K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$985K
Cost to Collect
$939K
Denial Rate Reduction
$929K
A/R Days Reduction
$571K
Clean Claim Rate
$30K
Total EBITDA Uplift$3.5M
Current EBITDA$-2.4M
+ RCM Uplift+$3.5M
Pro Forma EBITDA$1.1M
Current Margin-5.1%
Pro Forma Margin2.3%
WC Released (1x)$1.8M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.7M$18.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.7M$19.6M0.00x-100.0%
Bull Case9.0x11.0x$-3.3M$29.8M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.3M$31.5M0.00x-100.0%
Bear Case11.0x10.0x$-4.0M$2.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-4.0M$1.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 29 hospitals with 50-200 beds
  • Same-state prioritization (n=30)
  • Comp margins: P25=-16.0% / P50=-3.7% / P75=12.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.